Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Rapid identification of genomic structural variations with nanopore sequencing enables blood-based cancer monitoring

Jose Espejo Valle-Inclan, Christina Stangl, Anouk C. de Jong, Lisanne F. van Dessel, Markus J. van Roosmalen, Jean C.A. Helmijr, Ivo Renkens, Sam de Blank, Chris J. de Witte, John W.M. Martens, Maurice P.H.M. Jansen, Martijn P. Lolkema, Wigard P. Kloosterman
doi: https://doi.org/10.1101/19011932
Jose Espejo Valle-Inclan
1Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
2Oncode Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Stangl
1Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
2Oncode Institute
3Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anouk C. de Jong
4Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisanne F. van Dessel
4Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus J. van Roosmalen
1Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
5Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean C.A. Helmijr
4Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivo Renkens
1Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sam de Blank
1Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris J. de Witte
1Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
2Oncode Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John W.M. Martens
4Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maurice P.H.M. Jansen
4Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martijn P. Lolkema
4Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wigardkloosterman{at}gmail.com m.lolkema{at}erasmusmc.nl
Wigard P. Kloosterman
1Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
6Cyclomics, Utrecht, The Netherlands
7Frame Cancer Therapeutics, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wigardkloosterman{at}gmail.com m.lolkema{at}erasmusmc.nl
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Data Availability

Nanopore sequencing data is available in ENA and EGA as follows: COLO829 cell line: ENA accession ERX2765498. HGS-3 organoid line: EGA dataset accession EGAD00001005476 Patient material: EGA study accession EGAS00001003963

Back to top
PreviousNext
Posted November 15, 2019.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Rapid identification of genomic structural variations with nanopore sequencing enables blood-based cancer monitoring
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Rapid identification of genomic structural variations with nanopore sequencing enables blood-based cancer monitoring
Jose Espejo Valle-Inclan, Christina Stangl, Anouk C. de Jong, Lisanne F. van Dessel, Markus J. van Roosmalen, Jean C.A. Helmijr, Ivo Renkens, Sam de Blank, Chris J. de Witte, John W.M. Martens, Maurice P.H.M. Jansen, Martijn P. Lolkema, Wigard P. Kloosterman
medRxiv 19011932; doi: https://doi.org/10.1101/19011932
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Rapid identification of genomic structural variations with nanopore sequencing enables blood-based cancer monitoring
Jose Espejo Valle-Inclan, Christina Stangl, Anouk C. de Jong, Lisanne F. van Dessel, Markus J. van Roosmalen, Jean C.A. Helmijr, Ivo Renkens, Sam de Blank, Chris J. de Witte, John W.M. Martens, Maurice P.H.M. Jansen, Martijn P. Lolkema, Wigard P. Kloosterman
medRxiv 19011932; doi: https://doi.org/10.1101/19011932

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)